HALOZYME THERAPEUTICS IN Halozyme Therapeutics Inc

HALOZYME THERAPEUTICS IN Halozyme Therapeutics Inc is a security (CUSIP 40637HAJ8) tracked across SEC portfolio filings. 16 registered fund positions totaling $82.5M via N-PORT as of 2026-05-31.

Summary

Top fund holders (N-PORT)

Showing 15 of 16 fund positions by value.

FundRegistrantValue% of fund
Calamos Market Neutral Income FundCALAMOS INVESTMENT TRUST/IL$22.9M12.97%
CALAMOS CONVERTIBLE & HIGH INCOME FUNDCALAMOS CONVERTIBLE & HIGH INCOME FUND$9.9M96.41%
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUNDCALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND$9.1M94.29%
NYLI MacKay Convertible FundNEW YORK LIFE INVESTMENTS FUNDS$8.7M48.59%
Calamos Dynamic Convertible & Income FundCalamos Dynamic Convertible & Income Fund$7.6M111.73%
Putnam Convertible Securities FundPutnam Convertible Securities Fund$6.5M115.50%
Bancroft Fund LtdBancroft Fund Ltd$5.9M429.82%
Ellsworth Growth & Income Fund LtdEllsworth Growth & Income Fund Ltd$5.9M347.34%
Advent Convertible & Income FundADVENT CONVERTIBLE & INCOME FUND$2.4M40.08%
Gabelli Convertible & Income Securities Fund IncGabelli Convertible & Income Securities Fund Inc$2.4M284.52%
Virtus Global Allocation FundVirtus Strategy Trust$704K48.03%
Putnam Premier Income TrustPutnam Premier Income Trust$248K6.96%
Virtus Newfleet Multi-Sector Bond ETFETFis Series Trust I$70K1.65%
Loomis Sayles Senior Floating Rate and Fixed Income FundNatixis Funds Trust II$69K1.55%
Putnam High Yield FundPutnam High Yield Fund$52K0.63%

More